After years of debilitating depression, Kevin Matthews credits a transformative mushroom trip in 2011 as his turnaround. It allowed the clouds to clear and kind of gave me the perspective to see my life in a whole new context, he says.
Matthews, 34, doesnt look the part of a drug activist. Neatly dressed in a pale blue button-down, the young dad talks over the noise of clattering plates at a trendy Denver coffee shop about what fun it was to wander between parks that night. When he laughs, his brown eyes crinkle behind no-nonsense rectangular glasses that look like they belong on a teacher rather than an impassioned organizer trying to make magic mushrooms mainstream.
Yet as Decriminalize Denvers campaign manager, Matthews drove his citys push to decriminalize psilocybin, the active ingredient in mushrooms that causes hallucinations. Initiative 301 secured 50.5 percent of the vote in May, making Denver the first U.S. city to decriminalize the drug for those over 21 years old. Arrests for possession or use of psilocybin are now Denvers lowest law enforcement priority, though the drug still cant be sold or used for medical treatment.
After the narrow victory, Matthews and others from the campaign launched the nonprofit Society for Psychedelic Outreach, Reform and Education (yes, thats SPORE). Matthews, who will be the groups executive director, supports city officials who provide extra training to law enforcement focused on harm reduction. He hopes SPORE will evolve into an information and strategy hub for other grassroots campaigns as psychedelics gain political attention nationwide. Oakland, California, decriminalized psychoactive plants and fungi in June, while medical legalization of psilocybin could be on Oregons ballot next year and petitions are circling California for a 2020 decriminalization ballot measure.
Unlike the legalization of cannabis, this mushroom push isnt expected to create a booming industry or begin correcting decades of criminal inequities (psilocybin is identified in less than 0.5 percent of drug lab reports). Instead, supporters point to a small but growing body of research suggesting that psilocybin can be an effective tool to treat post-traumatic stress disorder, depression and addiction. Growing acceptance of marijuana helped pave the way. This shouldnt be considered alternative anymore, says Matthews. We have a national emergency right now with our mental health and addiction crisis.
This shouldnt be considered alternative anymore.
While this was Matthews first brush with organizing, hes been oriented by a sense of duty for decades. Since age 9, the Denver native dreamed of joining the Army and following in the footsteps of his adoptive father and grandfather. In 2005, he headed to West Point, where he was treated for depression. Suicidal ideation led to a medical discharge in 2008.
The discharge crushed him. The military doesnt really have the cultural infrastructure to work with people who are suffering from major depression, Matthews says, steady and soft-spoken, as sunlight pours into the caf. He moved home with his father and bounced among odd jobs. Today, he speaks openly about the sense of abandonment he traces to being adopted and without a mother figure. It took a cocktail of therapy, yoga, meditation and alternative spirituality for him to reach a place of clarity.
Self-medicating with mushrooms was part of that soul-searching. In 2011, Matthews moved in with Sheva, who would become his wife. (They met at a poker game: I got my ass kicked, he says with a laugh.) The couple worked at an outdoor rehabilitation center for at-risk youth until 2013, when the company shut down, after which they packed up their Subaru and moved to Mendocino, California. They lived off the grid in the redwood forest until Shevah became pregnant; in 2014, they returned to Denver back into the real world, Matthews says.
By 2017 he was working as a social media consultant and became captivated by the idea that psilocybin could alleviate others suffering as well as his own. Matthews helped to craft the ballot initiative, found the 10-person committee, canvas for signatures and coordinate more than 100 volunteers, with a boost of $48,000 in campaign donations.
An expanding body of research has been exploring psilocybins therapeutic potential to treat obsessive-compulsive disorder, cigarette and alcohol dependence, and treatment-resistant depression. Some research also indicates low abuse and dependence rates. A University of California, San Francisco pilot study suggests it is feasible to combine medically supervised psilocybin use with regular group therapy, says Brian Anderson, a UCSF psychiatrist with a background in substance use (the study has not yet been published).
Still, Anderson urges caution, saying psilocybin use can go wrong for example, triggering psychotic episodes in people with schizophrenia and must take place in highly controlled settings. Neither Denvers nor Oaklands initiatives authorize doctors to recommend psilocybin as treatment, though Oregons ballot measure would allow medical use. Decriminalization at a local level is not legalization, and its not regulation, Anderson says.
Theres also the broad cadre of public health and safety concerns about recreational use. Trips, which can last up to six hours, cause hallucinations that impair judgment. People on psilocybin have died jumping from buildings or walking into traffic. Matthews understands these concerns: SPOREs focus has shifted to educating people about how to use mushrooms safely (e.g., knowing strains and appropriate dosage) through TV public service announcements, radio spots and billboards, possibly in conjunction with city government. After seeing his success in Denver, I expect that he will be aggressive in his efforts to educate the population and decriminalize its use, says Denver District Attorney Beth McCann, who brought in Matthews for a psilocybin primer after the initiative passed.
While advocates note that hallucinogenic plants have been used in community settings since the shamans and medicine men of antiquity, modern psychedelic politics remains in its infancy. Organizing efforts have bubbled up in cities like Chicago, Washington, D.C., Phoenix and Dallas, while medical research on the drug continues. Matthews is fully aware that national curiosity, scrutiny and criticism will focus on Denver as the petri dish of this experiment. In many ways, he says, we kind of catalyzed this movement for the rest of the country.
See the original post:
- Are NDEs caused by carbon dioxide overload? And what about psychedelics? - Patheos - June 24th, 2020
- ATAI dives into digital therapeutics to boost mental health care - FierceBiotech - June 24th, 2020
- 'People Should Have the Fundamental Right To Change Their Consciousness' - Reason - June 24th, 2020
- Revive Therapeutics betting on psychedelics and potential COVID-19 treatment Bucillamine - Proactive Investors USA & Canada - June 20th, 2020
- These Psychedelic Drugs May Be Key to Revolutionizing Weight Loss Treatment - Yahoo Finance - June 20th, 2020
- Champignon Brands CEO Dr Roger McIntyre authors studies appearing in two leading scientific journals - Proactive Investors USA & Canada - June 20th, 2020
- The effects of psychedelics on the brain's "consciousness conductor" - New Atlas - June 17th, 2020
- Psilocybin Dulls Activity in Brain Region Linked With Consciousness - Psych Congress Network - June 17th, 2020
- Champignon Brands revamps its brand identity to better reflect its scientific focus on psychedelic medicine - Proactive Investors UK - June 17th, 2020
- Mota Ventures Appoints Roger C. Clinton as Member of Advisory Board to Verrian GmbH - Its Psilocybin Research Subsidiary - Stockhouse - June 17th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week - Yahoo Finance - June 13th, 2020
- New Psychedelics Stocks and Acquisitions | 2020-06-08 | Investing News - Stockhouse - June 13th, 2020
- Pure Extracts: The Second Wave of Psychedelic Operators - The Deep Dive - June 13th, 2020
- New analysis claims the FDA rushed ketamine's approval for depression treatment - Big Think - June 13th, 2020
- How Liv Vasquez Uses Plants & Food for Wellness and Healing - Thrillist - June 13th, 2020
- Companies are starting to bet big on psychedelic drugs to treat US mental health epidemic - Proactive Investors USA & Canada - June 6th, 2020
- CHECK IT OUT: New from Lady Gaga; take a wild ride; beach reading; and a screen gem - Wicked Local - June 6th, 2020
- Dr. Bronner's Soaps Wants to Protect You From COVIDand Legalize Your Right to Magic Mushrooms - Mother Jones - June 6th, 2020
- 6 celebrities wildest psychedelic trips, as told by themselves - Insider - INSIDER - June 1st, 2020
- Rate and Review: Have a Good Trip - The Independent Florida Alligator - June 1st, 2020
- First-of-Its-Kind Study Hints at How Psilocybin Works in The Brain to Dissolve Ego - ScienceAlert - June 1st, 2020
- Codebase says psychedelic investee Red Light Holland debuts on CSE with ticker TRIP - Proactive Investors USA & Canada - June 1st, 2020
- Todd Shapiro of Red Light Holland on 'magic truffles' and the multi-billion dollar psychedelics market - InvestorIntel - June 1st, 2020
- This Trippy Oregon Theme Park Is A Low-Key Psychedelic Playground - Thrillist - May 15th, 2020
- EGF Theramed Appoints George Anstey to Board of Directors - Benzinga - May 15th, 2020
- Empower Clinics and EuroLife Brands Close Definitive Agreement and Sign Multi-Year Multi-National Licence Agreement - GuruFocus.com - May 15th, 2020
- Have a Good Trip Demystifies Psychedelics - The New Republic - May 14th, 2020
- Investing in Psychedelics - Energy and Capital - May 14th, 2020
- Psilocybin May be the Key to Treating a Range of Health Issues, Including Obesity - Baystreet.ca - May 14th, 2020
- Movie review: Netflix's 'Have a Good Trip' is only a mild high - Eagle-Tribune - May 14th, 2020
- Psychedelics - Alcohol and Drug Foundation - May 10th, 2020
- Celebrities share LSD trips in Netflix documentary 'Have A Good Trip' - Insider - INSIDER - May 10th, 2020
- The Queen of Consciousness Driving Psychedelic Study and Advocacy - Filter - May 10th, 2020
- The 'Billions' Stock Watch: It's Time For Psychedelics And Subterfuge - UPROXX - May 10th, 2020
- Have a Good Trip: Netflix release and cast as celebrities recall mind-bending experiences - Mirror Online - May 10th, 2020
- From "Solar Opposites" to "Midnight Gospel," recent otherworldly animation is worth the head-trip - Salon - May 10th, 2020
- Netflix Reveals Celebrities' Wildest Drug Trips, From Anthony Bourdain to Carrie Fisher - The Daily Beast - May 10th, 2020
- Psychedelic mushrooms for depression: 'This is the one that changed things' - DW (English) - April 26th, 2020
- MindMed wants to develop a drug to help end a bad LSD trip - Fast Company - April 26th, 2020
- Netflixs The Midnight Gospel Is a Profoundly Weird Psychedelic Trip You Want To Take - Mashable India - April 26th, 2020
- Professor describes uses and history of hallucinogens - The Daily Evergreen - April 26th, 2020
- Media Central moves to provide coverage on emerging Psychedelics and eGames sectors - Proactive Investors USA & Canada - April 26th, 2020
- This video game does the same things to your brain as magic mushrooms - Happy Mag - April 26th, 2020
- Inborn Psychedelia on White Nights' Into the Lap of the Ancient Mother - Invisible Oranges - April 26th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Yahoo Finance - April 9th, 2020
- Psychedelic mushrooms could affect the brain long after its active ingredient leaves the system - The Next Web - April 9th, 2020
- We Could Be Taking Psychedelics to Help Treat Mental Illness in Just Five Years - Newsweek - April 7th, 2020
- Magic mushrooms to treat depression? COMPASS Pathways pushes forward with U.S. patent for psilocybin therapy - Straight.com - April 7th, 2020
- Key Insights from PSYCH: The Psychedelics as Medicine Report - Prohibition Partners - March 18th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Benzinga - March 18th, 2020
- With No Progress in Therapy, NYC Couple Turns to Psychedelics for Help - NBC New York - March 13th, 2020
- Upscale Psychedelics Therapy Center Opens On New Yorks 5th Avenue - Forbes - March 13th, 2020
- Why Kevin O'Leary is betting on psychedelics - Wealth Professional - March 13th, 2020
- Learning the hard way that psychedelic drug use can have long-term consequences - Dailyuw - March 13th, 2020
- Forget taking a pill a day. Canada is using psychedelics to revolutionize the way we treat mental health and addiction - The GrowthOp - March 13th, 2020
- High Stakes: Will The Legalization Of Psychedelics Mimic That Of Cannabis? Will It Learn From Its Mistakes? - Benzinga - March 13th, 2020
- Scientists Just Proved These Two Brain Networks Are Key to Consciousness - Singularity Hub - March 13th, 2020
- Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week - MarketWatch - March 13th, 2020
- Podcast Host Joe Rogan Is Steadily Documenting A Psychedelic Record Of The 21st Century - Forbes - February 27th, 2020
- Empower Clinics to create psilocybin and psychadelics division leveraging corporate wellness and franchise clinic network - Proactive Investors USA... - February 27th, 2020
- The Psilocybin Movement Is Like The Cannabis Movement (Except When It's Not) - Benzinga - February 27th, 2020
- Researchers went to festivals to study psychedelic drugs and found they left people feeling happy and connected hours after the high wore off -... - January 22nd, 2020
- Psychedelics and Their 'Mystical Effects' in the Real World - Medscape - January 22nd, 2020
- Psychedelic Events Are Going Mainstream, Where The Much-Maligned Mushroom Industry Focuses On Mental Health - Forbes - January 18th, 2020
- Psychedelics have 'extraordinarily potent' anti-inflammatory power. Is there a place for them in mainstream medicine? - Genetic Literacy Project - January 18th, 2020
- Silicon Valley Is Micro-Dosing Magic Mushrooms To Boost Their Careers - Forbes - January 18th, 2020
- NYC To Host Economics Of Psychedelics Investing Summit - Benzinga - January 18th, 2020
- The Best FREE Things to Do for the Next Week - My New Orleans - January 18th, 2020
- Photos of the Stuff That Fascinates People While They're Tripping On LSD - VICE - January 18th, 2020
- Rats on DMT hint at the benefits of psychedelic microdosing - Inverse - December 31st, 2019
- BEYOND LOCAL: Would you ever consider psychedelics to treat PTSD? - SooToday.com - December 31st, 2019
- A Trailblazer of Global Consciousness: Ram Dass Led the Way - Psychology Today - December 31st, 2019
- The Psychedelic Renaissance and the importance of drug policy reform - Open Access Government - December 13th, 2019
- Magic Mushrooms Move Closer to Mainstream Medicine As VC-Backed Compass Touts Safety, Positive Mood Alteration - Karma - December 13th, 2019
- Miami Clinics Use Ketamine IV Therapy to Help Treat Depression and PTSD - Miami New Times - December 13th, 2019
- Andy Frasco Talks Finding Emotional Balance With Psychedelics On 'Psychedelics Today' Podcast [Listen] - Live for Live Music - November 30th, 2019
- Will psychedelics be available commonly in the near future? - BPhrm Dv - November 30th, 2019
- Letters to the Editor: Psychedelics on their way - Valley Advocate - November 30th, 2019
- Scientists Have a Fascinating New Map of the Human Brain on DMT - VICE - November 30th, 2019
- Hes a fungi: U.S. health agency asks researcher to give it the lowdown on psilocybin mushrooms - The GrowthOp - November 30th, 2019